THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 22 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $33,089,000 | +5.0% | 35,675,000 | +7.5% | 0.75% | +2.9% |
| Q1 2022 | $31,516,000 | -11.7% | 33,175,000 | -10.2% | 0.73% | -5.9% |
| Q4 2021 | $35,674,000 | -22.5% | 36,925,000 | -25.7% | 0.78% | -35.9% |
| Q3 2021 | $46,013,000 | +60.4% | 49,675,000 | +65.6% | 1.22% | +53.0% |
| Q2 2021 | $28,693,000 | +93.5% | 30,000,000 | +106.9% | 0.80% | +34.5% |
| Q1 2021 | $14,826,000 | -49.8% | 14,500,000 | -37.7% | 0.59% | +37.8% |
| Q1 2017 | $29,550,000 | -18.6% | 23,290,000 | -26.1% | 0.43% | -33.6% |
| Q4 2016 | $36,304,000 | – | 31,500,000 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 6,000,000 | $5,827,000 | 3.55% |
| DeepCurrents Investment Group LLC | 21,223,000 | $20,803,000 | 1.80% |
| ZAZOVE ASSOCIATES LLC | 19,230,000 | $18,725,000 | 1.77% |
| Mohican Financial Management, LLC | 500,000 | $494,000 | 1.61% |
| Castle Creek Arbitrage, LLC | 5,149,000 | $5,015,000 | 1.47% |
| LINDEN ADVISORS LP | 62,688,000 | $61,071,000 | 1.40% |
| Verition Fund Management LLC | 10,817,000 | $10,504,000 | 0.41% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,100,000 | $23,451,000 | 0.32% |
| Baupost Group | 30,000,000 | $29,213,000 | 0.24% |
| SSI INVESTMENT MANAGEMENT LLC | 2,763,000 | $2,676,000 | 0.22% |